PUBLISHED FOR OPPOSITION
on 10 Dec 2024
Last Applicant/ Owned by
4539 Metropolitan Ct
Frederick
MD
21704
Serial Number
98354359 filed on 12th Jan 2024
Registration Number
N/A
Correspondent Address
Walter W. Richardson
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
OSPREYBIO
Research and development in the field of multigenic therapy; Research and development services in the field of gene and cell therapy, namely, vector design for research and commercial purposes Chemical compositions, namely, kits containing solid substrates for the storage and distribution of nucleic acids other than for medical or veterinary purposes
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Research and development in the field of multigenic therapy; Research and development services in the field of gene and cell therapy, namely, vector design for research and commercial purposes
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Chemical compositions, namely, kits containing solid substrates for the storage and distribution of nucleic acids other than for medical or veterinary purposes
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98354359
Mark Type
No Service Mark
Attorney Docket Number
No 15580018MA
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 10th Dec 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 10th Dec 2024 | PUBLISHED FOR OPPOSITION |
| 04th Dec 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 15th Nov 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 09th Oct 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 09th Oct 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 09th Oct 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 08th Aug 2024 | NON-FINAL ACTION E-MAILED |
| 08th Aug 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 08th Aug 2024 | ASSIGNED TO EXAMINER |